BRVE on Nasdaq

Braveheart Bio, Inc.

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with another stock.

  • TickerBRVE on Nasdaq
  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business addressOne Letterman Dr., Bldg. A, Ste. A4-300, San Francisco, Ca 941292
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

Recent filings

  1. Sep 10, 2026SCHEDULE 13D/A
  2. Sep 8, 20268-K
  3. Sep 8, 202610-Q
  4. Aug 18, 2026SCHEDULE 13D
  5. Aug 14, 2026SCHEDULE 13G
  6. Aug 14, 2026SCHEDULE 13D
  7. Aug 14, 20263
  8. Aug 11, 20264
  9. Aug 11, 20264
  10. Aug 11, 20264
  11. Aug 10, 20264 OWNERSHIP DOCUMENT
  12. Aug 7, 20268-K
  13. Aug 7, 20264
  14. Aug 7, 20264
  15. Aug 7, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3